JONESBORO, Ark. (KAIT) – A new blood test could help doctors identify Alzheimer’s-related changes as much as 10 years before symptoms appear, according to research presented at the Alzheimer’s Association International Conference.
The test measures levels of a blood biomarker known as p-tau217. Researchers say those levels can help predict whether amyloid plaques, brain changes linked to Alzheimer’s disease, may be building up.
Delores Hurst, executive director of the Arkansas chapter of the Alzheimer’s Association, said blood testing could also help close a long-standing gap between specialists and primary care providers in identifying patients who may be at risk…